Singapore
Fund managers in Asia often lack the incentives to mark down their portfolios for secondaries sales.
1
Temasek-backed ClavystBio co-leads Allay Therapeutics' Series D
2
HealthKois launches $300m fund to back early growth-stage firms in India
3
Temasek names SG's ex-deputy PM Teo Chee Hean as new chairman
4
Wealth fund Danantara Indonesia considers stake in Grab-GoTo deal: report
5
China’s SparkEdge Capital hits first close of second RMB fund
More Stories
Dymon Asia plots sale of Texas Chicken’s Singapore-based parent Select Group
Singapore insurtech bolttech closes Series C round at $147m
Singapore robo advisor Syfe closes Series C round at $80m
Carlyle said to have joined investors circling Starbucks China stake
Navis to sell Thai smart card maker dzcard to Japan’s Toppan Security
Investors today are more focused on exits and distributions than ever before.
If retail investors access bottom-quartile funds, we risk a mis-selling scandal.
India
The uncertainty exacerbates the myriad challenges that GPs are already grappling with.
Greater China
SPACs and RTOs were once viewed as unconventional, but they’re becoming increasingly routine.
For too long, businesses have fixated on India’s wealthiest consumers.
IT/BPO businesses rarely feature on the radar of VCs. Can AI change that?
But late-stage exit mechanisms and faster dispute resolutions remain pain points.
The message was clear—there is a need to supplement government spending with private capital.
The message is clear — India’s future as a superpower will be built on technological excellence.
